Christophe Bourdon – SVP EMEA, Alexion Pharmaceuticals
Specializing in ultra-rare diseases, Alexion targets patient populations of less than 20 patients per million. Christophe Bourdon discusses…
Interview: Dr. Andrea Michael Meyer – General Manager,…
Dr. Andrea Michael Meyer, general manager of Sanofi Genzyme Switzerland, reveals how the Swiss business has been experiencing year-on-year…
Bernhard Neidhart – Head of Office for Economy and Labor,…
Bernhard Neidhart, head of Office for Economy and Labor in Zug, introduces us to the Canton of Zug and explains how the region became a hotspot for…
Interview: Monika Rühl – CEO, economiesuisse, Switzerland
For the eighth year in a row the World Economic Forum has ranked Switzerland first in both global competitiveness and in innovation; economiesuisse…
Interview: Michelle Lock – Biopharmaceutical Vice President…
Michelle Lock describes the positive challenges that come with expanding a biopharmaceutical business that possesses a well-regarded pipeline, and…
Interview: Dr. André T. Dahinden – General Manager…
Dr. André T. Dahinden, General Manager of Amgen Switzerland, talks about their four cutting-edge products that will help drive future growth, reveals…
Interview: Michael Cobas Meyer – General Manager, Eli Lilly…
Michael Cobas Meyer of Eli Lilly Switzerland reveals how these are very exciting times for the company, particularly given an extremely rich pipeline…
Interview: Walter P. Hölzle – President, vips, Switzerland
Walter P. Hölzle, president of vips, discusses the current priorities of the association, the importance of innovation, and the challenges of the…
Interview: Kari Sarvanto – Group CEO, Primex Pharmaceuticals,…
Kari Sarvanto introduces Primex, an innovative fast-growing company spearheading a new pharmaceutical business model, strongly focusing on…
Interview: Gaelle Meaude – Operations Director, Thea…
Gaelle Meaude, operations director of Thea Switzerland, talks about building an effective sales and marketing team over the last few years; why the…
Interview: Nicolas Hug – Head of Industrial Biotech COE…
Nicolas Hug reveals how UCB´s new facility in Bulle, Switzerland, is one of the largest microbial derived pharmaceuticals plants in Europe; how the…
Interview: Dr. Oliver Bleck – General Manager, Roche…
As the home market, Switzerland and Roche’s Swiss pharma operations play an important and pioneering role within Roche’s global organization, with…